Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

Tenascin-C (TNC, Tnc)

  • Richard P. TuckerEmail author
  • Matthias Chiquet
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_101622


Historical Background

Tenascins are extracellular matrix glycoproteins with subunits composed of epidermal growth factor (EGF)-like repeats, fibronectin type III (FNIII) domains, and a C-terminal fibrinogen-related domain (Chiquet-Ehrismann and Tucker 2011). Tenascins trimerize via heptad repeats found near their N-terminus, and, in at least some cases, two tenascin trimers can form a hexabrachion. In most vertebrates there are four paralogous tenascins: tenascin-C, tenascin-R, tenascin-W, and tenascin-X. The best studied and first to be discovered is tenascin-C, which was independently identified as an antigen or extract in tumors, tendons, muscles, bones, and developing brain. The name tenascin was adopted for this protein by Chiquet-Ehrismann and colleagues from the Latin verbs tenere (to hold) and nasci(to be born) reflecting its prominent...

This is a preview of subscription content, log in to check access.


  1. Asparuhova MB, Ferralli J, Chiquet M, Chiquet-Ehrismann R. The transcriptional regulator megakaryoblastic leukemia-1 mediates serum response factor-independent activation of tenascin-C transcription by mechanical stress. FASEB J. 2011;25(10):3477–88. doi:10.1096/fj.11-187310.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Chiovaro F, Chiquet-Ehrismann R, Chiquet M. Transcriptional regulation of tenascin genes. Cell Adhes Migr. 2015;9:34–47.CrossRefGoogle Scholar
  3. Chiquet M, Fambrough DM. Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J Cell Biol. 1984;98(6):1926–36.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Chiquet M, Gelman L, Lutz R, Maier S. From mechanotransduction to extracellular matrix gene expression in fibroblasts. Biochim Biophys Acta. 2009;1793:911–20.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell. 1986;47(1):131–9.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Chiquet-Ehrismann R, Kalla P, Pearson CA, Beck K, Chiquet M. Tenascin interferes with fibronectin action. Cell. 1988;53(3):383–90.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Chiquet-Ehrismann R, Chiquet M. Tenascins: regulation and putative functions during pathological stress. J Pathol. 2003;200:488–99.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Chiquet-Ehrismann R, Tucker RP. Tenascins and the importance of adhesion modulation. Cold Spring Harb Perspect Biol. 2011;3(5). pii: a004960.  https://doi.org/10.1101/cshperspect.a004960.
  9. Chiquet-Ehrismann R, Orend G, Chiquet M, Tucker RP, Midwood KS. Tenascins in stem cell niches. Matrix Biol. 2014;37:112–23.  https://doi.org/10.1016/j.matbio.2014.01.007.CrossRefPubMedPubMedCentralGoogle Scholar
  10. De Laporte L, Rice JJ, Tortelli F, Hubbell JA. Tenascin C promiscuously binds growth factors via its fifth fibronectin type III-like domain. PLoS One. 2013;8(4):e62076.  https://doi.org/10.1371/journal.pone.0062076.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Derr LB, Chiquet-Ehrismann R, Gandour-Edwards R, Spence J, Tucker RP. The expression of tenascin-C with the AD1 variable repeat in embryonic tissues, cell lines and tumors in various vertebrate species. Differentiation. 1997;62(2):71–82.PubMedPubMedCentralCrossRefGoogle Scholar
  12. Erickson HP, Inglesias JL. A six-armed oligomer isolated from cell surface fibronectin preparations. Nature. 1984;311(5983):267–9.PubMedPubMedCentralCrossRefGoogle Scholar
  13. Goh FG, Piccinini AM, Krausgruber T, Udalova IA, Midwood KS. Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation. J Immunol. 2010;184(5):2655–62.  https://doi.org/10.4049/jimmunol.0903359.CrossRefPubMedPubMedCentralGoogle Scholar
  14. Grumet M, Hoffman S, Crossin KL, Edelman GM. Cytotactin, an extracellular matrix protein of neural and non-neural tissues that mediates glia-neuron interaction. Proc Natl Acad Sci U S A. 1985;82(23):8075–9.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Hendaoui I, Tucker RP, Zingg D, Bichet S, Schittny J, Chiquet-Ehrismann R. Tenascin-C is required for normal Wnt/β-catenin signaling in the whisker follicle stem cell niche. Matrix Biol. 2014;40:46–53.  https://doi.org/10.1016/j.matbio.2014.08.017.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Huang W, Chiquet-Ehrismann R, Moyano JV, Garcia-Pardo A, Orend G. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res. 2001;61(23):8586–94.PubMedPubMedCentralGoogle Scholar
  17. Lowy CM, Oskarsson T. Tenascin C in metastasis: a view from the invasive front. Cell Adhes Migr. 2015;9(1–2):112–24.  https://doi.org/10.1080/19336918.2015.1008331.CrossRefGoogle Scholar
  18. Mackie EJ, Tucker RP, Halfter W, Chiquet-Ehrismann R, Epperlein HH. The distribution of tenascin coincides with pathways of neural crest cell migration. Development. 1988;102(1):237–50.PubMedPubMedCentralGoogle Scholar
  19. Mackie EJ, Tucker RP. Tenascin in bone morphogenesis: expression by osteoblasts and cell type-specific expression of splice variants. J Cell Sci. 1992;103(3):765–71.PubMedPubMedCentralGoogle Scholar
  20. Midwood KS, Valenick LV, Hsia HC, Schwarzbauer JE. Coregulation of fibronectin signaling and matrix contraction by tenascin-C and syndecan-4. Mol Biol Cell. 2004;15(12):5670–7.PubMedPubMedCentralCrossRefGoogle Scholar
  21. Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, Chan E, Drexler S, Sofat N, Kashiwagi M, Orend G, Brennan F, Foxwell B. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med. 2009;15(7):774–80.  https://doi.org/10.1038/nm.1987.CrossRefPubMedPubMedCentralGoogle Scholar
  22. Orend G, Chiquet-Ehrismann R. Tenascin-C induced signaling in cancer. Cancer Lett. 2006;244(2):143–63.PubMedPubMedCentralCrossRefGoogle Scholar
  23. Piccinini AM, Midwood KS. Endogenous control of immunity against infection: tenascin-C regulates TLR4-mediated inflammation via microRNA-155. Cell Rep. 2012;2(4):914–26.  https://doi.org/10.1016/j.celrep.2012.09.005.CrossRefPubMedPubMedCentralGoogle Scholar
  24. Reulen HJ, Poepperl G, Goetz C, Gildehaus FJ, Schmidt M, Tatsch K, Pietsch T, Kraus T, Rachinger W. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy. J Neurosurg. 2015;123(3):760–70.  https://doi.org/10.3171/2014.12.JNS142168.CrossRefPubMedPubMedCentralGoogle Scholar
  25. Tucker RP, Spring J, Baumgartner S, Martin D, Hagios C, Poss PM, Chiquet-Ehrismann R. Novel tenascin variants with a distinctive pattern of expression in the avian embryo. Development. 1994;120(3):637–47.PubMedPubMedCentralGoogle Scholar
  26. Tucker RP, Chiquet-Ehrismann R. Tenascin-C: its functions as an integrin ligand. Int J Biochem Cell Biol. 2015;65:165–8.  https://doi.org/10.1016/j.biocel.2015.06.003.CrossRefPubMedPubMedCentralGoogle Scholar
  27. Udalova IA, Ruhmann M, Thomson SJ, Midwood KS. Expression and immune function of tenascin-C. Crit Rev Immunol. 2011;31(2):115–45.PubMedPubMedCentralCrossRefGoogle Scholar
  28. Yamada KM, Yamada SS, Pastan I. The major cell surface glycoprotein of chick embryo fibroblasts is an agglutinin. Proc Natl Acad Sci U S A. 1975;72(8):3158–62.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of Cell Biology and Human AnatomyUniversity of CaliforniaDavisUSA
  2. 2.Department of Orthodontics and Dentofacial OrthopedicsUniversity of BernBernSwitzerland